This presentation is an UPDATE of the previous one, related to High Risk PCI in very sick patients compares the Use of IABP versus Impella. Includes the most recents results of the SHOCK II TRIAL published in NEJM August 27, 2012 and presented at the European Society of Cardiology in Munich in the last few days.